Health Care & Life Sciences » Pharmaceuticals | Johnson & Johnson

Johnson & Johnson | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
71,263
74,334
70,200
71,937
76,481
81,534
Cost of Goods Sold (COGS) incl. D&A
22,411
22,950
21,577
21,637
25,107
27,186
Gross Income
48,852
51,384
48,623
50,300
51,374
54,348
SG&A Expense
30,029
30,455
30,255
28,950
31,809
33,095
EBIT
18,823
20,929
18,368
21,350
19,565
21,253
Unusual Expense
3,758
2,406
1,679
1,576
3,387
4,138
Non Operating Income/Expense
787
2,494
2,920
438
2,127
1,467
Interest Expense
472
518
552
763
1,017
1,194
Pretax Income
15,471
20,563
19,196
19,803
17,673
17,999
Income Tax
1,640
4,240
3,787
3,263
16,373
2,702
Consolidated Net Income
13,831
16,323
15,409
16,540
1,300
15,297
Net Income
13,831
16,323
15,409
16,540
1,300
15,297
Net Income After Extraordinaries
13,831
16,323
15,409
16,540
1,300
15,297
Net Income Available to Common
13,831
16,323
15,409
16,540
1,300
15,297
EPS (Basic)
4.81
5.70
5.48
5.93
0.47
5.61
Basic Shares Outstanding
2,809
2,815
2,772
2,737
2,692
2,682
EPS (Diluted)
4.81
5.70
5.48
5.93
0.47
5.61
Diluted Shares Outstanding
2,877
2,864
2,813
2,789
2,745
2,729
EBITDA
22,927
24,824
22,114
25,104
25,207
28,182
Non-Operating Interest Income
74
67
128
368
385
611

About Johnson & Johnson

View Profile
Address
One Johnson & Johnson Plaza
New Brunswick New Jersey 08933
United States
Employees -
Website http://www.jnj.com
Updated 07/08/2019
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.